Subnets / SN55
NIOME SN55
NIOME (subnet 55) is a Bittensor subnet held by 1,760 unique coldkeys. Its liquidity pool holds 5.9k τ, with the alpha token trading at 0.0021 τ. Roughly 3% of tracked holders are in profit — most bought in above today's price. Seller exhaustion is elevated: 89% of recent sellers have emptied their wallets, thinning the supply overhang. Full insider flow, whale tracking and the complete proprietary factor set for NIOME are available to SubnetStats subscribers.
ALPHA PRICE
0.0021 τ
IN TAO
HOLDERS
1,760
UNIQUE COLDKEYS
POOL DEPTH
5.9k τ
TAO IN POOL
7D MOMENTUM
-2.5%
ALPHA vs TAO
Project activity
Everything NIOME is built to do starts from one stubborn fact: medicine needs far more genomic data than the world can safely provide.
Real patient genomes are slow to collect, expensive, wrapped in privacy law, and skewed toward a few populations. The data medicine needs most i
The $GENOME to $NIOME migration is in motion, and the conviction is stacking up fast.
50,000 NIOME is already locked to conviction on Subnet 55. That is NIOME committed to the network for the long term, held in conviction and off the open market. More gets locked with every migr
This morning, Aldo de Pape, subnet owner of NIOME on Subnet 55, spoke at @RobertGordonUni’s School of Pharmacy, Applied Sciences and Public Health on what it takes to build a biotech company with AI.
NIOME is a live example of it: a company using AI and Bittensor to move genomic
The $GENOME → $NIOME migration is open.
The official portal is live, linked in this post, and the first 5% is now available. Your GENOME on Base converts into a locked NIOME conviction position on Subnet 55, verified before any GENOME is burned.
Across the full migration, as m
The migration is two days away, starting with the first 5%. Your GENOME on Base converts into a locked NIOME position on Bittensor Subnet 55. Here is everything you need to be ready, and to do it safely.
𝗪𝗵𝗮𝘁 𝘆𝗼𝘂'𝗹𝗹 𝗻𝗲𝗲𝗱
Two wallets, set up before the day:
• A Base wallet holdi
Here is why we do what we do.
‘UK to invest £100m in 'world first' AI Biosecurity Lab’ 🧬
https://t.co/u5RmPLQCxQ
It started in 2018 with a single idea: your genome belongs to you.
Back then we were a small team with a conviction that the most personal data a person carries, the blueprint of who they are, should never be something taken, sold, or left exposed. So we built a place to keep it
Two people take the same medicine at the same dose. One gets better. The other feels nothing, or has a dangerous reaction. Often the difference is not the drug. It is their genes.
A set of liver enzymes, with names like CYP2C19 and CYP2C9, decides how your body handles many comm
Cannot wait for this one! 🎙️
A NIOME future is now. Join us! 🧬
Your genome belongs to you. That’s what NIOME is built to protect.
The sickle cell CRISPR challenge is complete, and drug response is next.
The $GENOME to $NIOME migration begins October 28.
Across the full migration, that could bring roughly 1,500 to 2,000 ($500k+) TAO into
In the Hash Rate podcast, @markjeffrey asked Aldo de Pape where he stands on the debate over subnet token prices.
Mark Jeffrey: There’s a big discussion right now about subnet token price and liquidity. Where do you land on it?
Aldo de Pape: I’d want people investing in the sub
10 million synthetic CRISPR experiments, complete on Subnet 55.
That is the full run of the network's CRISPR gene-editing work, built and scored by miners, with no real patient records involved. These experiments model the kind of editing behind conditions like sickle cell: pred
The migration date is set. Here is the reason any of this exists in the first place.
Two numbers worth sitting with: 133 million health records breached in 2024, and 185 million in 2025. Genomic data is the most personal information there is, and it's being stolen at scale. 23an
The wait is over. The $GENOME to $NIOME migration goes live on October 28.
The first batch will move 5% of GENOME’s snapshot market capitalisation into NIOME on Subnet 55, marking the start of a carefully phased migration that will continue in batches until completion.
Safety i
When Aldo de Pape sat down with @markjeffrey, he mentioned a new challenge going live the week after.
That challenge is now here: our new drug-response challenge, pharmacogenomics, the science of how your genes decide the way you respond to medication.
So it's a good moment to
Synthetic genomics is shifting from editing what already exists to designing genomes from the ground up.
The piece covers four paths: de novo genome design, AI-assisted genome design, programmable genome architecture, and the eventual creation of synthetic cells.
The constraint
https://t.co/aUEnQ89Z37
We are beyond excited to announce the launch of our Decentralized Pharmacogenomic Inference Network 🧬
A live subnet designed to advance pharmacogenomic genotype-to-phenotype inference through decentralized computation. 🎉
The network challenges miners to analyze realistic, syn
One question comes up as soon as people hear the migration is staged: why only 5% first? Why not move everything at once and be done with it?
The answer comes down to protecting the price, for everyone involved.
Here is the mechanism. NIOME is a Bittensor alpha token, and its p
Our founder, Aldo de Pape, joined @markjeffrey on Hash Rate to walk through Subnet 55.
The conversation covered genomic data breaches and custody risks, the challenges of scaling real patient data for research, and how NIOME generates privacy-safe synthetic genomic profiles.
Th
What if you could combine two species into one genome, rebuild the machinery inside a cell, or bring an extinct organism's DNA back to life?
That is the frontier Part 2 of our synthetic genomics series explores.
The same drive to understand life at scale is what NIOME brings to
https://t.co/s7Lm6ZjQZt
We can now build genomes from scratch, not just read them.
Part 1 of our synthetic genomics series covers three ways scientists are doing it:
• Restructuring
• Recoding
• Minimisation
Each one lets researchers test how genomes shape life at the chromosome level. And it is the
https://t.co/JCgFwygafM
The $GENOME to NIOME migration is moving from plan to action. Here is how it will actually roll out.
The migration happens in batches rather than all at once, and the first batch is now confirmed: 5% of $GENOME's snapshot market capitalisation, migrating into NIOME on Subnet 55.
SELLERS DRAINED
89%
28D SELLERS EMPTIED OUT
CAPITULATION
-0.15
BOUNCE COMPOSITE (z)
HEAT 7D
0.62×
VOLUME ÷ POOL DEPTH
HOLDERS IN PROFIT
3%
TRACKED WALLETS · ENTRY BELOW PRICE
WHAT'S CARRYING THE PRICE · 30DORGANICemission rank #76 · below the bar (rank 32)
30D RETURN
+5.5%
ALPHA vs TAO
WITHOUT CHAIN BUYS
+5.5%
SAME 30 DAYS, PROTOCOL BID REMOVED
CHAIN SHARE OF BUYING
0%
CHAIN BUYS vs TRADERS' NET
CHAIN BUYS / DAY
0 τ
PROTOCOL BUYING ITS ALPHA
See who's buying and selling NIOME — every trade classified miner / validator / owner / outsider, plus holder cost basis and the full 23-factor screener.
OPEN THE INSIDER TAPE →